by investoropportunity | Apr 30, 2024 | Company Research, Home Page Feature Articles
According to the Centers for Medicare and Medicaid Services, Americans spent $4.4 trillion on healthcare in 2022, ~$3 trillion of this spending flowed through health insurance companies. Healthcare spending is forecast to top $7 trillion in 2031. What makes Oscar...
by investoropportunity | Mar 15, 2023 | Company Research, Health, Home Page Feature Articles, Technology, Uncategorized
PharmAla is the first for-profit company to synthesize clinical-grade (GMP) MDMA and make it available for sale to both researchers and qualified patients. PharmAla will increasingly develop a target on its back for acquisition and we expect a rise in marketcap via...
Recent Comments